Regulation of Plasminogen Activator System in Lung Cancer
Author Information
Author(s): H.-H. Heidtmann, K. Havemann, R. Schwartz-Albiez
Primary Institution: Philipps University Marburg; German Cancer Research Center
Hypothesis
How do growth factors EGF, TGF-alpha, and TGF-beta regulate the plasminogen activator system in non-small cell lung cancer cell lines?
Conclusion
Growth factors EGF, TGF-alpha, and TGF-beta modulate the secretion of t-PA and PAI in non-small cell lung cancer cell lines.
Supporting Evidence
- All cell lines produced u-PA, but growth factors had minimal effect on its activity.
- TGF-beta stimulated the formation of PAI-complexes in certain cell lines.
- Cell lines differed in their response to growth factors, indicating variability in PA regulation.
Takeaway
This study looks at how certain growth factors affect the way cancer cells break down proteins, which can help them spread.
Methodology
The study involved treating various non-small cell lung cancer cell lines with growth factors and measuring the secretion of plasminogen activators and inhibitors.
Limitations
The study's findings may not fully represent in vivo conditions due to the presence of non-tumor cells in fresh tumor samples.
Participant Demographics
The study used several human non-small cell lung cancer cell lines of squamous and large cell origin.
Want to read the original?
Access the complete publication on the publisher's website